VRCA- Verrica Pharmaceuticals Inc.

Across the last three months, Verrica Pharmaceuticals Inc.'s insiders have accumulated 42,230 shares worth roughly $211K on balance.

VRCA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Manning Paul B	3.96M	$16.79M	-
CEO	Rieger Jayson	207.6K	$1.02M	-
COO	Zawitz David	27.0K	$134.5K	-
CFO	Kirby John J.	24.0K	$118.1K	-
Dir	Eichenfield Lawrence	16.0K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 18, 2026	Kirby John J.	Interim CFO	Buy	5,000	$4.93	$24,650.00	+26.4%	-	-
Aug 18, 2026	Rosenberg Noah L.	CMO	Buy	6,230	$4.91	$30,609.60	+264.3%	-	-
Aug 17, 2026	Zawitz David	Chief Operating Officer	Buy	6,000	$4.98	$29,880.00	+28.6%	-	-
Aug 17, 2026	Rieger Jayson	CEO And President	Buy	25,000	$5.03	$125,750.00	+13.7%	-	-
Nov 25, 2025	Rieger Jayson	CEO And President	Buy	94,311	$4.24	$400,114.42	+106.8%	+9.4%	-
Nov 25, 2025	Kirby John J.	Interim CFO	Buy	3,536	$4.24	$15,001.48	+65.2%	+9.4%	-
Nov 25, 2025	Zawitz David	Chief Operating Officer	Buy	10,000	$4.24	$42,425.00	+90.9%	+9.4%	-
Nov 25, 2025	Rosenberg Noah L.	CMO	Buy	2,357	$4.24	$9,999.57	New	+9.4%	-
Nov 25, 2025	Manning Paul B54	Director, 10% Owner	Buy	4,126,142	$4.24	$17,505,157.44	-530.5%	+9.4%	-
Mar 17, 2025	Hayes Christopher G.70	Chief Legal Officer	Sell	4,315	$0.65	$2,804.75	-2.4%	+1.3%	-3.0%